- Report
- July 2025
- 291 Pages
Global
From €5213EUR$5,850USD£4,522GBP
- Report
- July 2025
- 193 Pages
Global
From €5213EUR$5,850USD£4,522GBP
- Report
- July 2025
- 224 Pages
Global
From €5213EUR$5,850USD£4,522GBP
- Report
- July 2025
- 194 Pages
Global
From €5213EUR$5,850USD£4,522GBP
- Report
- July 2025
- 291 Pages
Global
From €5213EUR$5,850USD£4,522GBP
- Report
- July 2025
- 183 Pages
Global
From €5213EUR$5,850USD£4,522GBP
- Report
- July 2025
- 179 Pages
Global
From €5213EUR$5,850USD£4,522GBP
- Report
- July 2025
- 193 Pages
Global
From €5213EUR$5,850USD£4,522GBP
- Report
- July 2025
- 277 Pages
Global
From €5213EUR$5,850USD£4,522GBP
- Report
- July 2025
- 590 Pages
Global
From €5213EUR$5,850USD£4,522GBP
- Report
- August 2024
- 166 Pages
Global
From €2228EUR$2,500USD£1,933GBP
- Report
- October 2024
- 209 Pages
Global
From €2228EUR$2,500USD£1,933GBP
- Report
- April 2025
- 175 Pages
Global
From €4001EUR$4,490USD£3,471GBP
- Report
- April 2025
- 200 Pages
Global
From €4001EUR$4,490USD£3,471GBP
- Report
- March 2025
- 200 Pages
Global
From €4001EUR$4,490USD£3,471GBP
- Report
- February 2025
- 200 Pages
Global
From €4001EUR$4,490USD£3,471GBP
- Report
- February 2025
- 200 Pages
Global
From €4001EUR$4,490USD£3,471GBP
- Report
- February 2025
- 200 Pages
Global
From €4001EUR$4,490USD£3,471GBP
- Report
- February 2025
- 200 Pages
Global
From €4001EUR$4,490USD£3,471GBP
- Report
- February 2025
- 200 Pages
Global
From €4001EUR$4,490USD£3,471GBP

T Cell Therapies are a type of biotechnology that involves the use of a patient's own T cells to treat diseases. T cells are a type of white blood cell that play a key role in the body's immune system. T Cell Therapies involve the extraction of T cells from a patient, engineering them to recognize and attack specific targets, and then reintroducing them into the patient's body. This type of therapy has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. It has also been used to treat autoimmune diseases, such as rheumatoid arthritis and Crohn's disease.
T Cell Therapies are a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing and commercializing T Cell Therapies. Other companies, such as Gilead Sciences, Celgene, and Regeneron, are also investing in the field. Show Less Read more